prognost valu serum protein breast carcinoma cell sever breast carcinoma cell line explant tumor exampl dysplast breast tissu serum protein alpha alpha-lipoprotein vitro protein immunoperoxidas techniqu breast carcinoma year present carcinoma wherea alpha-lipoprotein marker relationship clinic outcom alpha-lipoprotein unfavor determin wherea lesion favor evolut taken marker similar weak associ five-year surviv rate patient favor group unfavor group grade tumor marker favor signific prognosi grade tumor stratif patient number posit unfavor marker strike result eight percent patient none unfavor marker dead year lesion unfavor marker 